Researchers have conducted a comprehensive review of immune checkpoint inhibitor-associated myocarditis. The condition is one of several toxicities linked to immune checkpoint inhibitors, which can also cause interstitial lung disease and other cardiovascular issues. Studies are examining the pathogenesis, diagnosis, and management of these toxicities, including myocarditis, which can sometimes be treated with rescue therapy or mimic other cardiac conditions.